GreenMark Biomedical Inc.
PrivateLast Round
Grant
Nov 11, 2025
Total Funding Raised
$7.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GreenMark Biomedical Inc. operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was a Grant round in November 2025.
GreenMark Biomedical Inc. is a dental technology company that develops non-invasive diagnostic and treatment products for dental caries and sensitivity using a starch nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GreenMark Biomedical Inc. Comparables
Compare GreenMark Biomedical Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incisive Technologies | 83% | |
| vVARDIS | 78% | |
| BioMin Technologies Limited | 77% |
For institutional investors. Book with your work email.
GreenMark Biomedical Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 11, 2025 | ||||
| Grant | Jul 16, 2025 | ||||
| Grant | Apr 3, 2025 | ||||
| Grant | May 16, 2024 | ||||
| Convertible Debt | Jan 26, 2022 | ||||
Convertible Debt | Aug 24, 2020 |
For institutional investors. Book with your work email.
GreenMark Biomedical Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Translational Resource Center | Grant |
| Ann Arbor SPARK | Convertible Debt |
| Biosciences Research & Commercialization Center | Convertible Debt, Seed |
| Michigan Investment in New Technology Startups | Convertible Debt, Seed |
| Michigan Rise | Convertible Debt |
| National Institute of Dental and Craniofacial Research | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 1052% MoM, reaching 42K.
- Apr 17, 2026
Monthly visitors increased 236% MoM, reaching 7.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 25, 2026
GreenMark Biomedical Inc. is developing regenerative medicine products through its “Targeted Remineralization Treatment Using Mineral Loaded Starch Nanoparticles” project, which receives up to $297,615 in additional funding to advance noninvasive mineralization of early-stage dental decay with the Universities of Michigan and Pittsburgh and the Wyss Institute at Harvard in Michigan on Aug 25th '26.
For institutional investors. Book with your work email.
GreenMark Biomedical Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GreenMark Biomedical Inc.'s valuation, stock price, and market status.
Is GreenMark Biomedical Inc. a public or private company?
GreenMark Biomedical Inc. is a private company.
What is the current stock price of GreenMark Biomedical Inc.?
GreenMark Biomedical Inc. is a private company, so its shares have no public market price. Caplight tracks GreenMark Biomedical Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GreenMark Biomedical Inc. worth (valuation)?
Valuation information for GreenMark Biomedical Inc. is not publicly available.
Can I buy GreenMark Biomedical Inc. stock?
GreenMark Biomedical Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GreenMark Biomedical Inc.'s last funding round?
GreenMark Biomedical Inc.'s most recent funding round was Grant on November 11, 2025.
Who are the main investors in GreenMark Biomedical Inc.?
Key investors in GreenMark Biomedical Inc. include ID Ventures, Michigan Rise and Red Cedar Ventures, BlueWater Angels.
Will GreenMark Biomedical Inc. IPO soon?
No public IPO plans have been announced for GreenMark Biomedical Inc..
How can I track GreenMark Biomedical Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GreenMark Biomedical Inc.'s shares on secondary markets.